Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/5250

TDMS Study 96007-01 Pathology Tables

NTP Experiment-Test: 96007-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT18
Study Type: CHRONIC                                  WITH AVERAGE SEVERITY GRADES[b]                              Date: 10/01/03
Route: GAVAGE                                   TOXIC EQUIVALENCY FACTOR EVALUATION (PCB-126)                     Time: 12:01:01

                                                         FINAL #3/RATS




       Facility:  Battelle Columbus Laboratory

       Chemical CAS #:  57465-28-8

       Lock Date:  01/09/01

       Cage Range:  All

       Reasons For Removal:    25022 Accidently Killed                 25018 Dosing Accident
                               25019 Moribund Sacrifice                25020 Natural Death
                               25021 Terminal Sacrifice

       Removal Date Range:     All

       Treatment Groups:       Include 001    0 NG/KG
                               Include 003    30 NG/KG
                               Include 004    100     NG/KG
                               Include 005    175     NG/KG
                               Include 006    300     NG/KG
                               Include 007    550     NG/KG
                               Include 008    1000    NG/KG
                               Include 009    1000 NG/KG/STOP
























a  Number of animals examined microscopically at site and number of animals with lesion
b  Average severity grade (1-minimal;2-mild;3-moderate;4-marked)

                                                              Page   1


NTP Experiment-Test: 96007-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT18  
Study Type: CHRONIC                                  WITH AVERAGE SEVERITY GRADES[b]                              Date: 10/01/03    
Route: GAVAGE                                   TOXIC EQUIVALENCY FACTOR EVALUATION (PCB-126)                     Time: 12:01:01    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         SPRAGUE-DAWLEY RATS FEMALE                   0 NG/KG      30 NG/KG     100          175          300          550          
                                                                                NG/KG        NG/KG        NG/KG        NG/KG        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
DISPOSITION SUMMARY                                                                                                                 
                                                                                                                                    
  Animals Initially In Study                          98           98           98           98           98           98           
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                25           18           21           19           27           18           
    Natural Death                                     10            9            6           11            9           12           
    Accidently Killed                                  1            3                                                               
    Dosing Accident                                    2                                      1            1                        
  Survivors                                                                                                                         
    Natural Death                                                   1            1                                                  
    Terminal Sacrifice                                15           24           25           22           16           23           
                                                                                                                                    
  Animals Examined Microscopically                    53           55           53           53           53           53           
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Esophagus                                          (52)         (55)         (53)         (53)         (53)         (52)         
      Hemorrhage                                                                                                        1 [3.0]     
      Hyperplasia, Focal, Squamous                                               1 [1.0]                                            
      Muscularis, Degeneration                                                                             1 [2.0]                  
      Muscularis, Inflammation                         2 [1.0]      1 [1.0]                   1 [1.0]      1 [1.0]      2 [1.5]     
      Periesophageal Tissue, Inflammation,                                                                                          
        Suppurative                                                                                        1 [3.0]                  
   Intestine Large, Colon                             (52)         (55)         (53)         (53)         (53)         (51)         
      Hyperplasia, Adenomatous                                                   1 [3.0]                                            
      Inflammation                                                               1 [2.0]                                            
      Parasite Metazoan                                             1            2            1                                     
   Intestine Large, Rectum                            (52)         (55)         (53)         (52)         (53)         (52)         
      Infiltration Cellular, Lymphocyte                                          1 [2.0]                                            
      Inflammation, Chronic Active                                                            1 [2.0]                               
      Mineralization                                                1 [2.0]                                                         
      Parasite Metazoan                                2            2            3                         1                        
      Artery, Inflammation, Chronic Active                                                    1 [3.0]                               
   Intestine Large, Cecum                             (52)         (54)         (53)         (51)         (53)         (52)         
      Edema                                                         1 [2.0]                                                         
      Hyperplasia, Lymphoid                                                                                1 [2.0]                  
      Inflammation                                                  1 [1.0]                                                         
   Intestine Small, Duodenum                          (52)         (55)         (52)         (53)         (53)         (51)         
      Erosion                                          1 [2.0]                                                                      
   Intestine Small, Ileum                             (52)         (54)         (52)         (51)         (53)         (52)         
      Hyperplasia, Lymphoid                                                                                1 [2.0]                  
      Mineralization                                                1 [2.0]                                                         
      Epithelium, Hyperplasia                                                                 1 [2.0]                               
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
b  Average severity grade (1-minimal;2-mild;3-moderate;4-marked)                                                                    
                                                                                                                                    
                                                             Page    2                                                              
                                                                                                                                   
NTP Experiment-Test: 96007-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT18  
Study Type: CHRONIC                                  WITH AVERAGE SEVERITY GRADES[b]                              Date: 10/01/03    
Route: GAVAGE                                   TOXIC EQUIVALENCY FACTOR EVALUATION (PCB-126)                     Time: 12:01:01    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         SPRAGUE-DAWLEY RATS FEMALE                   0 NG/KG      30 NG/KG     100          175          300          550          
                                                                                NG/KG        NG/KG        NG/KG        NG/KG        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Serosa, Inflammation, Chronic Active             1 [3.0]                                                                      
   Liver                                              (53)         (55)         (53)         (53)         (53)         (51)         
      Angiectasis                                      3 [1.3]      8 [1.4]      4 [1.0]      1 [2.0]      1 [2.0]      2 [1.5]     
      Basophilic Focus                                 2            4            6            7            2            3           
      Basophilic Focus, Multiple                       5            6            4            6            2            2           
      Cholangiofibrosis                                             1 [2.0]      1 [2.0]      1 [2.0]      3 [1.7]     13 [1.8]     
      Clear Cell Focus                                 1            1                                                               
      Clear Cell Focus, Multiple                       1                                                                            
      Cytoplasmic Alteration                                                     1 [2.0]      1 [2.0]      1 [2.0]      1 [2.0]     
      Degeneration, Cystic                                                                                 1 [1.0]      1 [2.0]     
      Eosinophilic Focus                               6            4            7            4            2            3           
      Eosinophilic Focus, Multiple                     5            6            6           17           15           21           
      Fatty Change, Diffuse                            5 [1.2]      7 [1.0]     14 [1.4]     22 [1.1]     30 [1.1]     45 [1.4]     
      Fatty Change, Focal                              2 [1.5]      6 [1.3]      8 [1.5]      6 [1.5]      3 [1.7]      2 [1.0]     
      Hematopoietic Cell Proliferation                                                                                  1 [2.0]     
      Hepatocyte, Multinucleate                                     2 [1.0]     10 [1.1]     14 [1.0]     19 [1.3]     46 [1.5]     
      Hepatodiaphragmatic Nodule                       1            1                         1                                     
      Hyperplasia, Nodular                                                                    1            3           26           
      Inflammation                                    36 [1.1]     40 [1.1]     49 [1.2]     50 [1.2]     51 [1.2]     51 [1.4]     
      Mixed Cell Focus                                 4            6            7            3                         3           
      Mixed Cell Focus, Multiple                      17           18           25           29           30           26           
      Necrosis                                         4 [2.3]      2 [2.0]      5 [1.6]      8 [2.1]     11 [1.9]     15 [2.0]     
      Pigmentation                                     1 [1.0]     11 [1.3]     41 [1.2]     39 [1.6]     48 [1.9]     51 [2.3]     
      Toxic Hepatopathy                                             6 [1.2]     22 [1.0]     27 [1.0]     39 [1.3]     51 [2.4]     
      Vacuolization Cytoplasmic                                     1 [1.0]                                                         
      Artery, Inflammation, Chronic Active                                                    1 [2.0]      1 [2.0]      1 [2.0]     
      Bile Duct, Cyst                                  3 [1.7]      6 [2.3]                   2 [2.0]      3 [2.7]      8 [2.0]     
      Bile Duct, Fibrosis                              4 [1.0]      4 [1.5]      3 [1.3]      2 [1.0]      1 [1.0]      4 [1.0]     
      Bile Duct, Hyperplasia                           3 [1.3]      7 [1.6]      7 [1.6]     13 [1.4]     14 [1.2]     45 [1.8]     
      Hepatocyte, Degeneration                         3 [2.3]      1 [2.0]      1 [2.0]                   1 [1.0]      1 [1.0]     
      Hepatocyte, Hypertrophy                                      23 [1.1]     32 [1.2]     36 [1.3]     42 [1.4]     50 [2.3]     
      Oval Cell, Hyperplasia                                        1 [1.0]      6 [1.2]      7 [1.1]     10 [1.2]     38 [1.8]     
      Portal, Fibrosis                                                                                     2 [2.0]      1 [1.0]     
      Serosa, Inflammation                                          1 [2.0]                                                         
   Mesentery                                          (1)                       (4)          (2)          (7)          (13)         
      Inflammation, Chronic Active                     1 [4.0]                                                                      
      Artery, Inflammation, Chronic Active                                       2 [3.0]      2 [3.5]      6 [3.2]     10 [2.6]     
      Fat, Necrosis                                                              1 [3.0]                   1 [3.0]      1 [3.0]     
   Oral Mucosa                                        (1)          (1)          (3)          (4)          (2)          (6)          
      Gingival, Hyperplasia, Squamous                  1 [2.0]                   2 [1.0]      2 [2.0]                   4 [1.5]     
   Pancreas                                           (51)         (55)         (53)         (53)         (53)         (52)         
      Basophilic Focus                                              1                         1                                     
      Cyst                                                                                                              1 [2.0]     
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
b  Average severity grade (1-minimal;2-mild;3-moderate;4-marked)                                                                    
                                                                                                                                    
                                                             Page    3                                                              
                                                                                                                                   
NTP Experiment-Test: 96007-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT18  
Study Type: CHRONIC                                  WITH AVERAGE SEVERITY GRADES[b]                              Date: 10/01/03    
Route: GAVAGE                                   TOXIC EQUIVALENCY FACTOR EVALUATION (PCB-126)                     Time: 12:01:01    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         SPRAGUE-DAWLEY RATS FEMALE                   0 NG/KG      30 NG/KG     100          175          300          550          
                                                                                NG/KG        NG/KG        NG/KG        NG/KG        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Inflammation, Chronic Active                     5 [1.6]      1 [1.0]      3 [2.0]      4 [1.3]      4 [1.8]      6 [2.3]     
      Acinus, Atrophy                                  5 [2.0]      3 [1.3]      2 [2.5]      7 [1.6]      2 [2.5]     11 [2.2]     
      Acinus, Hyperplasia                                           1 [2.0]      1 [3.0]      1 [2.0]      1 [2.0]                  
      Acinus, Vacuolization Cytoplasmic                                          1 [1.0]      4 [1.5]      9 [1.0]     20 [1.1]     
      Artery, Inflammation, Chronic Active                          4 [2.0]      2 [3.0]      4 [2.5]      8 [2.5]     15 [2.5]     
      Artery, Mineralization                                        1 [2.0]                                             1 [2.0]     
      Duct, Hyperplasia                                                                                                 1 [4.0]     
      Duct, Inflammation, Chronic Active                                                                                2 [3.0]     
   Salivary Glands                                    (51)         (54)         (53)         (51)         (52)         (51)         
      Atrophy                                                                                 1 [1.0]      1 [2.0]                  
      Cyst                                                          1 [2.0]                                1 [2.0]                  
      Inflammation, Acute                                                                                  1 [1.0]                  
      Inflammation, Chronic Active                     1 [2.0]                                             1 [2.0]                  
   Stomach, Forestomach                               (52)         (55)         (53)         (53)         (53)         (51)         
      Edema                                            1 [3.0]                   1 [2.0]                   1 [2.0]                  
      Erosion                                                       1 [1.0]                                                         
      Hyperkeratosis                                                3 [1.7]      1 [2.0]      1 [1.0]      3 [1.7]      1 [2.0]     
      Hyperplasia, Squamous                            3 [1.7]      4 [2.0]      6 [1.8]      2 [2.0]      5 [1.8]      6 [1.7]     
      Inflammation, Acute                              1 [1.0]                                                                      
      Inflammation, Chronic Active                                  1 [3.0]      2 [2.0]      1 [2.0]      1 [2.0]                  
      Mineralization                                   1 [2.0]                   1 [3.0]      1 [2.0]                   1 [2.0]     
      Necrosis, Focal                                                            1 [2.0]                                            
      Ulcer                                            3 [2.0]      1 [2.0]                   1 [2.0]      3 [2.3]      2 [2.0]     
   Stomach, Glandular                                 (51)         (53)         (53)         (53)         (53)         (51)         
      Erosion                                          1 [2.0]      1 [2.0]                   1 [2.0]                               
      Metaplasia, Focal                                                          1 [2.0]                                            
      Mineralization                                   1 [2.0]      1 [3.0]                   1 [1.0]                               
   Tooth                                              (12)         (12)         (10)         (9)          (10)         (9)          
      Peridontal Tissue, Inflammation, Chronic                                                                                      
        Active                                         2 [2.5]                                                          1 [4.0]     
      Peridontal Tissue, Inflammation, Suppurative    10 [1.3]     12 [1.3]     10 [1.4]      9 [1.4]     10 [1.4]      8 [1.8]     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                       (53)         (55)         (53)         (53)         (53)         (53)         
      Aorta, Mineralization                            3 [1.3]      1 [3.0]      1 [3.0]                                2 [1.0]     
   Heart                                              (52)         (54)         (53)         (53)         (53)         (51)         
      Cardiomyopathy                                   9 [1.0]     16 [1.1]     17 [1.1]     16 [1.2]     24 [1.1]     28 [1.1]     
      Degeneration                                     1 [2.0]      1 [3.0]                                             1 [3.0]     
      Inflammation                                                  1 [2.0]                                                         
      Mineralization                                   1 [2.0]      1 [2.0]                                             1 [2.0]     
      Thrombosis                                       1 [2.0]                                                          1 [2.0]     
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
b  Average severity grade (1-minimal;2-mild;3-moderate;4-marked)                                                                    
                                                                                                                                    
                                                             Page    4                                                              
                                                                                                                                   
NTP Experiment-Test: 96007-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT18  
Study Type: CHRONIC                                  WITH AVERAGE SEVERITY GRADES[b]                              Date: 10/01/03    
Route: GAVAGE                                   TOXIC EQUIVALENCY FACTOR EVALUATION (PCB-126)                     Time: 12:01:01    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         SPRAGUE-DAWLEY RATS FEMALE                   0 NG/KG      30 NG/KG     100          175          300          550          
                                                                                NG/KG        NG/KG        NG/KG        NG/KG        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
CARDIOVASCULAR SYSTEM - CONT                                                                                                        
      Artery, Inflammation, Chronic Active                                                    1 [2.0]                               
      Epicardium, Inflammation, Chronic Active                                                             1 [3.0]                  
      Epicardium, Inflammation, Suppurative            2 [2.0]                                1 [4.0]                               
      Myocardium, Inflammation                                                                             1 [3.0]      1 [1.0]     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (52)         (55)         (53)         (53)         (53)         (52)         
      Angiectasis                                     11 [1.5]     13 [1.5]     25 [1.5]     19 [1.7]     20 [1.5]      8 [1.4]     
      Atrophy                                          1 [1.0]      3 [2.3]      5 [1.2]      3 [1.0]      5 [1.6]     19 [1.8]     
      Degeneration, Cystic                            11 [2.1]     14 [2.4]     10 [2.0]     14 [2.8]     14 [2.1]     16 [2.3]     
      Hyperplasia                                     23 [1.9]     21 [2.4]     27 [2.1]     25 [2.0]     25 [2.4]     31 [2.7]     
      Hypertrophy                                     34 [1.9]     41 [2.0]     40 [1.9]     41 [2.1]     40 [1.9]     41 [2.0]     
      Inflammation, Suppurative                                                  1 [1.0]                                            
      Mineralization                                   1 [2.0]                                                          1 [1.0]     
      Necrosis                                         1 [2.0]      1 [2.0]                   1 [3.0]      1 [2.0]      1 [2.0]     
      Thrombosis                                                                                                        1 [2.0]     
      Vacuolization Cytoplasmic                        5 [1.2]      3 [1.7]      5 [2.0]      2 [2.0]      9 [1.9]      4 [1.0]     
   Adrenal Medulla                                    (52)         (55)         (53)         (53)         (53)         (52)         
      Angiectasis                                                                2 [2.0]      1 [2.0]      2 [2.5]      2 [2.5]     
      Hyperplasia                                      8 [1.5]     18 [2.0]     11 [1.7]     11 [2.0]     12 [1.8]      6 [2.0]     
      Necrosis                                                                                1 [3.0]                               
   Islets, Pancreatic                                 (52)         (54)         (53)         (53)         (53)         (52)         
      Hyperplasia                                      1 [2.0]      2 [2.0]      1 [1.0]      1 [1.0]                   1 [1.0]     
   Parathyroid Gland                                  (47)         (50)         (48)         (46)         (49)         (47)         
      Hyperplasia                                                   1 [2.0]      1 [2.0]      2 [1.5]      1 [3.0]      1 [1.0]     
   Pituitary Gland                                    (51)         (54)         (53)         (53)         (53)         (53)         
      Angiectasis                                     14 [2.1]     15 [2.1]     22 [2.2]     12 [2.3]     16 [2.3]     19 [2.3]     
      Cyst                                                          3 [2.3]      1 [2.0]      1 [1.0]                   2 [2.5]     
      Cytoplasmic Alteration                                        1 [2.0]      1 [2.0]      1 [2.0]      3 [2.0]      1 [2.0]     
      Inflammation, Focal, Granulomatous                                                                                1 [2.0]     
      Necrosis                                                                                             1 [2.0]                  
      Pigmentation                                                                                         1 [2.0]                  
      Vacuolization Cytoplasmic                                     1 [2.0]      1 [1.0]                                            
      Pars Distalis, Hyperplasia                      18 [1.9]     20 [2.5]     23 [2.2]     17 [2.1]     21 [1.9]     26 [2.2]     
   Thyroid Gland                                      (52)         (55)         (52)         (51)         (52)         (50)         
      Angiectasis                                                   1 [2.0]      4 [2.0]                                            
      Cyst                                                                                    1 [2.0]                   1 [2.0]     
      C-Cell, Hyperplasia                             12 [1.9]     21 [1.7]     17 [1.5]     19 [1.8]     18 [1.9]     16 [1.9]     
      Follicle, Cyst                                                             1 [2.0]                                            
      Follicular Cell, Hyperplasia                                               1 [1.0]      1 [1.0]                               
      Follicular Cell, Hypertrophy                     9 [1.3]     13 [1.2]     13 [1.5]     17 [1.1]     28 [1.5]     26 [1.3]     
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
b  Average severity grade (1-minimal;2-mild;3-moderate;4-marked)                                                                    
                                                                                                                                    
                                                             Page    5                                                              
                                                                                                                                   
NTP Experiment-Test: 96007-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT18  
Study Type: CHRONIC                                  WITH AVERAGE SEVERITY GRADES[b]                              Date: 10/01/03    
Route: GAVAGE                                   TOXIC EQUIVALENCY FACTOR EVALUATION (PCB-126)                     Time: 12:01:01    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         SPRAGUE-DAWLEY RATS FEMALE                   0 NG/KG      30 NG/KG     100          175          300          550          
                                                                                NG/KG        NG/KG        NG/KG        NG/KG        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                     (50)         (55)         (52)         (50)         (53)         (52)         
      Hyperplasia                                                   1 [2.0]                                                         
      Hyperplasia, Squamous                                                      1 [1.0]                                            
      Inflammation                                    28 [1.5]     36 [1.4]     39 [1.7]     28 [1.6]     30 [1.4]     27 [1.3]     
      Duct, Cyst                                      29 [1.9]     32 [2.0]     34 [2.0]     37 [1.9]     39 [2.0]     42 [2.2]     
   Ovary                                              (52)         (54)         (53)         (52)         (52)         (52)         
      Atrophy                                         45 [4.0]     49 [4.0]     46 [4.0]     45 [4.0]     47 [4.0]     46 [4.0]     
      Cyst                                            12 [2.0]     17 [2.2]     17 [2.4]     15 [2.3]     16 [2.1]     18 [2.1]     
      Inflammation, Chronic Active                                                            1 [2.0]      1 [3.0]                  
      Inflammation, Suppurative                                     1 [1.0]                                             2 [2.5]     
      Necrosis                                                                                             1 [4.0]                  
      Artery, Inflammation, Chronic Active                                       1 [3.0]      1 [2.0]                               
   Oviduct                                            (1)          (1)                                    (1)          (3)          
      Cyst                                                                                                              1 [4.0]     
      Inflammation, Chronic Active                                                                         1 [3.0]                  
      Inflammation, Suppurative                        1 [2.0]      1 [1.0]                                             2 [2.5]     
   Uterus                                             (52)         (55)         (53)         (52)         (53)         (52)         
      Adenomyosis                                                   1 [2.0]                   1 [4.0]                   2 [2.5]     
      Cyst                                                          1 [3.0]                                                         
      Erosion                                                                    1 [2.0]                                            
      Hemorrhage                                                                              1 [2.0]      2 [3.0]      1 [3.0]     
      Inflammation, Chronic Active                                                            2 [3.0]      1 [4.0]      1 [2.0]     
      Inflammation, Granulomatous                      1 [2.0]                                                                      
      Inflammation, Suppurative                       12 [1.8]     12 [1.8]     11 [1.6]     16 [2.0]     10 [1.6]      6 [2.2]     
      Metaplasia, Squamous                            26 [1.6]     33 [1.9]     25 [2.1]     28 [2.3]     29 [1.8]     27 [2.2]     
      Thrombosis                                                                              1 [2.0]                   1 [3.0]     
      Ulcer                                                         1 [2.0]                                                         
      Vacuolization Cytoplasmic                                                  2 [2.0]                                            
      Artery, Inflammation, Chronic Active                                       1 [3.0]                                1 [3.0]     
      Cervix, Cyst                                                                                         1 [2.0]                  
      Cervix, Hyperplasia, Stromal                                                                                      1 [3.0]     
      Endometrium, Hyperplasia, Cystic                23 [1.7]     33 [2.1]     28 [1.8]     24 [2.5]     26 [2.0]     32 [2.2]     
      Epithelium, Hyperplasia                          1 [3.0]                                1 [3.0]                               
      Epithelium, Necrosis                                                       1 [2.0]      1 [2.0]                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
b  Average severity grade (1-minimal;2-mild;3-moderate;4-marked)                                                                    
                                                                                                                                    
                                                             Page    6                                                              
                                                                                                                                   
NTP Experiment-Test: 96007-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT18  
Study Type: CHRONIC                                  WITH AVERAGE SEVERITY GRADES[b]                              Date: 10/01/03    
Route: GAVAGE                                   TOXIC EQUIVALENCY FACTOR EVALUATION (PCB-126)                     Time: 12:01:01    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         SPRAGUE-DAWLEY RATS FEMALE                   0 NG/KG      30 NG/KG     100          175          300          550          
                                                                                NG/KG        NG/KG        NG/KG        NG/KG        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (53)         (55)         (53)         (53)         (53)         (53)         
      Angiectasis                                                                                                       1 [2.0]     
      Fibrosis                                                                   1 [3.0]                                            
      Hyperplasia                                     47 [3.4]     37 [3.2]     35 [3.3]     44 [3.3]     45 [3.2]     46 [3.2]     
   Lymph Node                                         (2)          (6)          (6)          (6)          (4)          (7)          
      Ectasia                                                                                 1 [2.0]                               
      Deep Cervical, Ectasia                                                     1 [2.0]                                            
      Inguinal, Hyperplasia, Plasma Cell                                         1 [2.0]                                            
      Inguinal, Pigmentation                                                     1 [2.0]                                            
      Lumbar, Ectasia                                                                                                   2 [2.0]     
      Lumbar, Hyperplasia                                                                                               1 [2.0]     
      Lumbar, Hyperplasia, Lymphoid                                 1 [2.0]                                                         
      Lumbar, Hyperplasia, Plasma Cell                                                        2 [2.5]      1 [3.0]                  
      Mediastinal, Ectasia                                          2 [1.5]      3 [2.0]                                            
      Mediastinal, Hemorrhage                                                    2 [2.0]      1 [2.0]      1 [2.0]                  
      Mediastinal, Hyperplasia, Lymphoid                                                                   1 [3.0]                  
      Mediastinal, Hyperplasia, Plasma Cell                                                                1 [2.0]      1 [3.0]     
      Mediastinal, Inflammation, Suppurative                                                               1 [2.0]                  
      Pancreatic, Hyperplasia, Plasma Cell                                                                              1 [2.0]     
   Lymph Node, Mandibular                             (52)         (53)         (51)         (51)         (52)         (51)         
      Ectasia                                          1 [2.0]      1 [3.0]      4 [2.0]      4 [2.5]      4 [2.0]      4 [2.5]     
      Hemorrhage                                                                                           1 [2.0]                  
      Hyperplasia, Lymphoid                                         1 [2.0]      1 [2.0]      1 [2.0]      2 [2.0]                  
      Hyperplasia, Plasma Cell                        18 [2.2]     24 [2.0]     31 [2.2]     21 [2.3]     29 [2.0]     11 [2.2]     
   Lymph Node, Mesenteric                             (52)         (54)         (52)         (52)         (53)         (51)         
      Atrophy                                                                    1 [3.0]                                            
      Ectasia                                          1 [2.0]                                                          1 [2.0]     
      Hemorrhage                                       2 [2.0]      3 [2.0]                   1 [2.0]      1 [2.0]                  
      Hyperplasia, Histiocytic                         3 [1.7]                                                          1 [2.0]     
      Hyperplasia, Plasma Cell                                                                             1 [2.0]                  
      Pigmentation                                                                                                      1 [1.0]     
   Spleen                                             (52)         (55)         (52)         (53)         (53)         (52)         
      Hematopoietic Cell Proliferation                39 [1.7]     43 [1.6]     46 [1.4]     45 [1.5]     41 [1.7]     42 [1.4]     
      Hyperplasia, Lymphoid                                                      1 [2.0]                   1 [2.0]      1 [3.0]     
      Necrosis                                                      1 [2.0]                                                         
      Pigmentation                                    49 [1.3]     50 [1.4]     51 [1.5]     51 [1.4]     52 [1.5]     52 [1.5]     
      Lymphoid Follicle, Atrophy                                    5 [2.6]      3 [2.0]      2 [1.5]      5 [2.0]      3 [2.3]     
      Red Pulp, Atrophy                                                          4 [2.0]      1 [2.0]      1 [2.0]                  
   Thymus                                             (50)         (52)         (46)         (48)         (41)         (49)         
      Atrophy                                         37 [2.5]     34 [2.6]     41 [2.8]     45 [2.8]     36 [3.3]     47 [3.5]     
      Fibrosis                                                                   1 [2.0]                                            
      Hemorrhage                                       1 [3.0]      1 [1.0]                                                         
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
b  Average severity grade (1-minimal;2-mild;3-moderate;4-marked)                                                                    
                                                                                                                                    
                                                             Page    7                                                              
                                                                                                                                   
NTP Experiment-Test: 96007-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT18  
Study Type: CHRONIC                                  WITH AVERAGE SEVERITY GRADES[b]                              Date: 10/01/03    
Route: GAVAGE                                   TOXIC EQUIVALENCY FACTOR EVALUATION (PCB-126)                     Time: 12:01:01    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         SPRAGUE-DAWLEY RATS FEMALE                   0 NG/KG      30 NG/KG     100          175          300          550          
                                                                                NG/KG        NG/KG        NG/KG        NG/KG        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
      Inflammation                                     1 [3.0]                                1 [3.0]                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (52)         (55)         (53)         (53)         (53)         (52)         
      Cyst                                             8 [1.8]      3 [1.7]      1 [4.0]      4 [3.3]      5 [2.6]      1 [2.0]     
      Fibrosis, Focal                                                                                      1 [2.0]                  
      Hyperplasia                                     32 [1.4]     33 [1.4]     30 [1.4]     29 [1.2]     21 [1.2]     23 [1.1]     
      Inflammation, Chronic Active                     1 [3.0]                                2 [3.0]      2 [2.0]                  
      Inflammation, Granulomatous                      2 [2.0]      2 [3.0]                   1 [2.0]                               
   Skin                                               (52)         (55)         (53)         (53)         (53)         (53)         
      Cyst, Squamous                                   1 [2.0]      1 [3.0]                                                         
      Ulcer                                                                      1 [2.0]                                            
      Dermis, Inflammation, Focal                      1 [2.0]                                                                      
      Subcutaneous Tissue, Inflammation,                                                                                            
        Suppurative                                                                           1 [2.0]                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (53)         (55)         (53)         (53)         (53)         (53)         
      Inflammation, Chronic Active                     1 [2.0]                                                                      
      Osteopetrosis                                                              1 [2.0]                   2 [2.0]                  
      Cartilage, Hypertrophy, Focal                                                                                     1 [2.0]     
   Skeletal Muscle                                    (1)          (1)          (1)                                                 
      Inflammation, Chronic Active                     1 [3.0]                                                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (53)         (55)         (53)         (53)         (53)         (53)         
      Hemorrhage                                                                                                        1 [3.0]     
      Hydrocephalus                                    1 [1.0]                   2 [2.0]                                1 [2.0]     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (53)         (55)         (53)         (53)         (53)         (51)         
      Congestion                                       1 [3.0]      1 [2.0]                                1 [2.0]                  
      Infiltration Cellular, Histiocyte               41 [1.7]     49 [1.7]     45 [1.7]     48 [1.6]     45 [1.6]     49 [1.7]     
      Inflammation, Chronic Active                     5 [1.4]      3 [1.3]                   1 [2.0]      1 [2.0]                  
      Inflammation, Granulomatous                      3 [1.7]                   2 [1.5]                                            
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
b  Average severity grade (1-minimal;2-mild;3-moderate;4-marked)                                                                    
                                                                                                                                    
                                                             Page    8                                                              
                                                                                                                                   
NTP Experiment-Test: 96007-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT18  
Study Type: CHRONIC                                  WITH AVERAGE SEVERITY GRADES[b]                              Date: 10/01/03    
Route: GAVAGE                                   TOXIC EQUIVALENCY FACTOR EVALUATION (PCB-126)                     Time: 12:01:01    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         SPRAGUE-DAWLEY RATS FEMALE                   0 NG/KG      30 NG/KG     100          175          300          550          
                                                                                NG/KG        NG/KG        NG/KG        NG/KG        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
RESPIRATORY SYSTEM - CONT                                                                                                           
      Inflammation, Suppurative                                                                                         1 [2.0]     
      Metaplasia, Squamous                             1 [2.0]                   1 [2.0]      2 [1.5]      3 [2.3]      9 [1.7]     
      Mineralization                                                1 [3.0]      1 [3.0]                                1 [2.0]     
      Thrombosis                                                    2 [2.5]                                             1 [2.0]     
      Alveolar Epithelium, Hyperplasia                12 [1.1]      1 [1.0]                   1 [3.0]      2 [1.0]                  
      Alveolar Epithelium, Metaplasia, Bronchiolar                 29 [1.3]     34 [1.6]     41 [1.8]     39 [1.7]     47 [2.1]     
      Serosa, Fibrosis                                                           2 [1.5]                                            
      Serosa, Inflammation, Chronic Active                          1 [2.0]                                                         
      Serosa, Inflammation, Suppurative                2 [2.5]                                1 [3.0]      1 [3.0]                  
      Vein, Thrombosis                                                                        1 [3.0]                               
   Nose                                               (53)         (54)         (52)         (53)         (52)         (53)         
      Nasolacrimal Duct, Inflammation                               1 [2.0]                   1 [2.0]      1 [2.0]                  
      Nasolacrimal Duct, Glands, Hyperplasia                                                                            1 [4.0]     
      Nasolacrimal Duct, Respiratory Epithelium,                                                                                    
         Hyperplasia                                                                                       1 [2.0]                  
      Nasopharyngeal Duct, Inflammation,                                                                                            
        Suppurative                                    1 [4.0]                   1 [3.0]                                            
      Olfactory Epithelium, Inflammation,                                                                                           
        Suppurative                                    1 [3.0]                   1 [3.0]                                            
      Respiratory Epithelium, Hyperplasia              2 [2.5]                   1 [2.0]      1 [2.0]      2 [2.0]      2 [2.5]     
      Respiratory Epithelium, Inflammation,                                                                                         
        Suppurative                                                              1 [3.0]                   1 [2.0]      1 [3.0]     
      Respiratory Epithelium, Metaplasia               1 [4.0]                                             1 [2.0]                  
      Turbinate, Cyst                                                                                                   1 [1.0]     
      Turbinate, Inflammation, Suppurative             2 [2.0]                   1 [2.0]      1 [1.0]      2 [2.5]                  
   Trachea                                            (53)         (55)         (53)         (53)         (53)         (52)         
      Inflammation                                     1 [2.0]                                                                      
      Peritracheal Tissue, Inflammation                1 [3.0]                                                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Ear                                                                                                    (1)                       
      Inflammation                                                                                         1 [1.0]                  
   Eye                                                (51)         (55)         (53)         (53)         (53)         (52)         
      Atrophy                                                                    1 [3.0]      1 [3.0]                               
      Cataract                                                                                             1 [3.0]      1 [3.0]     
      Edema                                                                                                1 [3.0]                  
      Anterior Chamber, Inflammation, Suppurative                                                                       1 [3.0]     
      Anterior Chamber, Ciliary Body, Cornea,                                                                                       
        Inflammation, Suppurative                                                1 [2.0]                                            
      Cornea, Inflammation, Suppurative                                                                                 1 [3.0]     
      Retina, Atrophy                                                            3 [2.3]      1 [3.0]                   1 [3.0]     
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
b  Average severity grade (1-minimal;2-mild;3-moderate;4-marked)                                                                    
                                                                                                                                    
                                                             Page    9                                                              
                                                                                                                                   
NTP Experiment-Test: 96007-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT18  
Study Type: CHRONIC                                  WITH AVERAGE SEVERITY GRADES[b]                              Date: 10/01/03    
Route: GAVAGE                                   TOXIC EQUIVALENCY FACTOR EVALUATION (PCB-126)                     Time: 12:01:01    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         SPRAGUE-DAWLEY RATS FEMALE                   0 NG/KG      30 NG/KG     100          175          300          550          
                                                                                NG/KG        NG/KG        NG/KG        NG/KG        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
SPECIAL SENSES SYSTEM - CONT                                                                                                        
      Retina, Degeneration                                                                                              1 [2.0]     
   Harderian Gland                                    (53)         (53)         (53)         (53)         (53)         (52)         
      Inflammation                                     2 [1.0]      3 [1.0]      6 [1.2]      6 [1.2]      3 [1.0]      3 [1.0]     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (53)         (55)         (53)         (53)         (53)         (52)         
      Calculus Micro Observation Only                                            1            1                         1           
      Casts Protein                                    4 [1.3]      3 [1.3]      1 [1.0]      6 [1.2]                               
      Cyst                                                                                    2 [1.5]                               
      Inflammation, Chronic Active                     2 [2.0]      2 [2.0]      1 [3.0]      1 [3.0]      1 [1.0]      1 [2.0]     
      Inflammation, Suppurative                                                  3 [1.0]                                1 [3.0]     
      Mineralization                                  32 [1.0]     39 [1.0]     44 [1.0]     44 [1.0]     44 [1.0]     39 [1.1]     
      Necrosis                                                                   1 [2.0]                   1 [3.0]      1 [3.0]     
      Nephropathy                                     32 [1.3]     29 [1.3]     38 [1.5]     35 [1.3]     38 [1.5]     42 [2.1]     
      Papilla, Angiectasis                                                                                 1 [2.0]                  
      Pelvis, Dilatation                               2 [2.0]      1 [3.0]                                             1 [2.0]     
      Pelvis, Inflammation, Chronic Active                          2 [2.5]      2 [2.5]      2 [2.5]                               
      Pelvis, Inflammation, Suppurative                2 [1.0]                                             3 [2.0]                  
      Renal Tubule, Accumulation, Hyaline Droplet                   1 [3.0]                                                         
      Renal Tubule, Dilatation                                                                1 [2.0]                               
      Transitional Epithelium, Hyperplasia             4 [2.0]      2 [2.5]      8 [1.9]      4 [2.5]      8 [1.6]      8 [2.3]     
   Ureter                                                                       (1)                                                 
      Mineralization                                                             1 [3.0]                                            
      Transitional Epithelium, Hyperplasia                                       1 [2.0]                                            
   Urinary Bladder                                    (51)         (54)         (53)         (52)         (52)         (52)         
      Edema                                                                                   1 [3.0]                               
      Hemorrhage                                                                              1 [2.0]                               
      Inflammation                                     4 [1.5]      6 [1.5]     10 [1.4]      6 [2.2]      7 [1.6]      4 [1.0]     
      Transitional Epithelium, Hyperplasia             1 [2.0]      1 [3.0]      1 [2.0]      2 [2.5]      1 [3.0]      2 [2.5]     
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
b  Average severity grade (1-minimal;2-mild;3-moderate;4-marked)                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                             Page   10                                                              
                                                                                                                                   
NTP Experiment-Test: 96007-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT18  
Study Type: CHRONIC                                  WITH AVERAGE SEVERITY GRADES[b]                              Date: 10/01/03    
Route: GAVAGE                                   TOXIC EQUIVALENCY FACTOR EVALUATION (PCB-126)                     Time: 12:01:01    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         SPRAGUE-DAWLEY RATS FEMALE                   1000         1000 NG/                                                         
                                                      NG/KG        KG/STOP                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
DISPOSITION SUMMARY                                                                                                                 
                                                                                                                                    
  Animals Initially In Study                          98           50                                                               
  Early Deaths                                                                                                                      
    Natural Death                                     12            6                                                               
    Moribund Sacrifice                                34           15                                                               
    Dosing Accident                                                 1                                                               
  Survivors                                                                                                                         
    Terminal Sacrifice                                 7           28                                                               
                                                                                                                                    
  Animals Examined Microscopically                    53           50                                                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Esophagus                                          (52)         (50)                                                             
      Cyst                                             1 [2.0]                                                                      
      Muscularis, Inflammation                                      1 [1.0]                                                         
   Intestine Large, Colon                             (53)         (50)                                                             
      Parasite Metazoan                                1                                                                            
   Intestine Large, Rectum                            (53)         (50)                                                             
      Parasite Metazoan                                1            1                                                               
   Intestine Small, Duodenum                          (53)         (50)                                                             
      Erosion                                          2 [1.5]                                                                      
      Ulcer                                            1 [3.0]                                                                      
      Epithelium, Hyperplasia                          1 [2.0]                                                                      
   Intestine Small, Jejunum                           (53)         (50)                                                             
      Hyperplasia, Lymphoid                            1 [2.0]                                                                      
   Liver                                              (53)         (50)                                                             
      Angiectasis                                      2 [2.0]      8 [1.5]                                                         
      Basophilic Focus                                 2            7                                                               
      Basophilic Focus, Multiple                       3            9                                                               
      Cholangiofibrosis                               22 [2.3]      1 [1.0]                                                         
      Clear Cell Focus                                              1                                                               
      Clear Cell Focus, Multiple                                    4                                                               
      Cytoplasmic Alteration                           1 [3.0]                                                                      
      Degeneration, Cystic                             2 [2.0]      3 [2.0]                                                         
      Eosinophilic Focus                               6            3                                                               
      Eosinophilic Focus, Multiple                    11            9                                                               
      Fatty Change, Diffuse                           47 [1.8]     12 [1.3]                                                         
      Fatty Change, Focal                                          11 [1.5]                                                         
      Hepatocyte, Multinucleate                       49 [1.7]     20 [1.0]                                                         
      Hepatodiaphragmatic Nodule                       1            1                                                               
      Hyperplasia, Nodular                            39                                                                            
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
b  Average severity grade (1-minimal;2-mild;3-moderate;4-marked)                                                                    
                                                                                                                                    
                                                             Page   11                                                              
                                                                                                                                   
NTP Experiment-Test: 96007-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT18  
Study Type: CHRONIC                                  WITH AVERAGE SEVERITY GRADES[b]                              Date: 10/01/03    
Route: GAVAGE                                   TOXIC EQUIVALENCY FACTOR EVALUATION (PCB-126)                     Time: 12:01:01    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         SPRAGUE-DAWLEY RATS FEMALE                   1000         1000 NG/                                                         
                                                      NG/KG        KG/STOP                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Inflammation                                    51 [1.2]     46 [1.2]                                                         
      Mixed Cell Focus                                 4            1                                                               
      Mixed Cell Focus, Multiple                       5           35                                                               
      Multinucleated                                                1 [1.0]                                                         
      Necrosis                                        17 [2.2]      4 [2.8]                                                         
      Pigmentation                                    48 [2.5]     48 [1.8]                                                         
      Toxic Hepatopathy                               49 [3.4]     15 [1.2]                                                         
      Bile Duct, Cyst                                 12 [2.0]      5 [2.2]                                                         
      Bile Duct, Fibrosis                              5 [1.2]      4 [1.0]                                                         
      Bile Duct, Hyperplasia                          45 [2.5]     16 [1.4]                                                         
      Bile Duct, Inflammation                          1 [2.0]                                                                      
      Hepatocyte, Degeneration                         7 [2.3]                                                                      
      Hepatocyte, Hypertrophy                         49 [3.4]     21 [1.4]                                                         
      Oval Cell, Hyperplasia                          40 [2.2]      1 [1.0]                                                         
      Portal, Fibrosis                                10 [2.1]                                                                      
      Serosa, Inflammation                             1 [1.0]                                                                      
   Mesentery                                          (11)                                                                          
      Inflammation, Chronic Active                     3 [2.7]                                                                      
      Artery, Inflammation, Chronic Active             7 [2.7]                                                                      
      Fat, Necrosis                                    1 [2.0]                                                                      
   Oral Mucosa                                        (11)         (6)                                                              
      Gingival, Cyst, Squamous                         1 [2.0]                                                                      
      Gingival, Hyperplasia, Squamous                  3 [2.7]      3 [2.3]                                                         
      Pharyngeal, Hyperplasia, Squamous                             1 [4.0]                                                         
   Pancreas                                           (51)         (48)                                                             
      Basophilic Focus                                              1                                                               
      Cyst                                             1 [2.0]                                                                      
      Inflammation, Chronic Active                    13 [2.2]      4 [1.5]                                                         
      Necrosis                                         1 [2.0]                                                                      
      Acinus, Atrophy                                 18 [2.1]      7 [1.4]                                                         
      Acinus, Vacuolization Cytoplasmic               23 [1.4]      1 [1.0]                                                         
      Artery, Inflammation, Chronic Active            11 [2.9]      1 [2.0]                                                         
      Duct, Dilatation                                 2 [4.0]                                                                      
      Duct, Hyperplasia                                1 [2.0]                                                                      
   Salivary Glands                                    (51)         (49)                                                             
      Atrophy                                                       1 [2.0]                                                         
      Cyst                                                          2 [3.0]                                                         
      Inflammation, Acute                              1 [2.0]                                                                      
   Stomach, Forestomach                               (53)         (50)                                                             
      Edema                                                         2 [2.0]                                                         
      Hyperkeratosis                                   2 [1.5]                                                                      
      Hyperplasia, Squamous                            8 [1.9]      2 [1.5]                                                         
      Mineralization                                   2 [2.0]                                                                      
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
b  Average severity grade (1-minimal;2-mild;3-moderate;4-marked)                                                                    
                                                                                                                                    
                                                             Page   12                                                              
                                                                                                                                   
NTP Experiment-Test: 96007-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT18  
Study Type: CHRONIC                                  WITH AVERAGE SEVERITY GRADES[b]                              Date: 10/01/03    
Route: GAVAGE                                   TOXIC EQUIVALENCY FACTOR EVALUATION (PCB-126)                     Time: 12:01:01    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         SPRAGUE-DAWLEY RATS FEMALE                   1000         1000 NG/                                                         
                                                      NG/KG        KG/STOP                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Ulcer                                            2 [2.0]                                                                      
   Stomach, Glandular                                 (53)         (50)                                                             
      Erosion                                                       1 [2.0]                                                         
      Inflammation, Chronic Active                     1 [1.0]                                                                      
      Mineralization                                   1 [2.0]                                                                      
      Artery, Inflammation, Chronic Active             1 [2.0]                                                                      
      Glands, Ectasia                                  1 [2.0]                                                                      
      Glands, Hyperplasia                              1 [2.0]                                                                      
   Tooth                                              (19)         (12)                                                             
      Peridontal Tissue, Fibrosis                      1 [3.0]      1 [3.0]                                                         
      Peridontal Tissue, Inflammation, Suppurative    18 [1.6]     11 [1.6]                                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                       (53)         (50)                                                             
      Aorta, Mineralization                                         1 [2.0]                                                         
   Heart                                              (51)         (50)                                                             
      Cardiomyopathy                                  32 [1.2]     15 [1.2]                                                         
      Mineralization                                                1 [2.0]                                                         
      Thrombosis                                       1 [3.0]      1 [2.0]                                                         
      Artery, Inflammation, Chronic Active                          1 [1.0]                                                         
      Endocardium, Myocardium, Inflammation, Acute     1 [3.0]                                                                      
      Epicardium, Inflammation, Chronic Active         1 [2.0]                                                                      
      Epicardium, Inflammation, Suppurative                         1 [4.0]                                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (53)         (50)                                                             
      Angiectasis                                      1 [2.0]     14 [1.7]                                                         
      Atrophy                                         30 [2.2]      9 [1.7]                                                         
      Degeneration, Cystic                            10 [2.2]     20 [2.4]                                                         
      Hyperplasia                                     24 [2.5]     26 [2.0]                                                         
      Hypertrophy                                     41 [1.8]     42 [2.4]                                                         
      Inflammation, Suppurative                                     1 [2.0]                                                         
      Mineralization                                   1 [2.0]                                                                      
      Necrosis                                         2 [1.5]      2 [1.5]                                                         
      Vacuolization Cytoplasmic                       17 [1.9]      6 [1.5]                                                         
   Adrenal Medulla                                    (53)         (50)                                                             
      Hyperplasia                                      1 [2.0]      9 [1.4]                                                         
   Parathyroid Gland                                  (46)         (44)                                                             
      Cyst                                                          1 [2.0]                                                         
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
b  Average severity grade (1-minimal;2-mild;3-moderate;4-marked)                                                                    
                                                                                                                                    
                                                             Page   13                                                              
                                                                                                                                   
NTP Experiment-Test: 96007-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT18  
Study Type: CHRONIC                                  WITH AVERAGE SEVERITY GRADES[b]                              Date: 10/01/03    
Route: GAVAGE                                   TOXIC EQUIVALENCY FACTOR EVALUATION (PCB-126)                     Time: 12:01:01    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         SPRAGUE-DAWLEY RATS FEMALE                   1000         1000 NG/                                                         
                                                      NG/KG        KG/STOP                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Hyperplasia                                                   2 [1.5]                                                         
   Pituitary Gland                                    (53)         (48)                                                             
      Angiectasis                                      9 [2.1]     14 [2.3]                                                         
      Cyst                                             1 [1.0]      1 [3.0]                                                         
      Cytoplasmic Alteration                                        1 [2.0]                                                         
      Pars Distalis, Hyperplasia                      17 [1.9]     17 [2.0]                                                         
   Thyroid Gland                                      (48)         (47)                                                             
      Angiectasis                                                   1 [2.0]                                                         
      Atrophy                                          1 [4.0]                                                                      
      Infiltration Cellular, Lymphocyte                1 [2.0]                                                                      
      C-Cell, Hyperplasia                             19 [1.7]     18 [1.8]                                                         
      Follicular Cell, Hyperplasia                     1 [4.0]                                                                      
      Follicular Cell, Hypertrophy                    16 [1.3]     22 [1.4]                                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                     (51)         (48)                                                             
      Inflammation                                    22 [1.3]     32 [1.6]                                                         
      Duct, Cyst                                      45 [2.3]     39 [1.9]                                                         
   Ovary                                              (53)         (50)                                                             
      Atrophy                                         33 [3.9]     47 [4.0]                                                         
      Cyst                                            11 [2.5]     17 [2.3]                                                         
   Oviduct                                            (1)          (2)                                                              
      Inflammation, Suppurative                        1 [3.0]      2 [3.0]                                                         
   Uterus                                             (53)         (50)                                                             
      Hemorrhage                                       1 [2.0]                                                                      
      Inflammation, Chronic Active                                  1 [4.0]                                                         
      Inflammation, Suppurative                        4 [2.5]     11 [2.2]                                                         
      Metaplasia, Squamous                            11 [2.4]     28 [2.0]                                                         
      Endometrium, Hyperplasia, Cystic                 9 [1.8]     31 [2.0]                                                         
      Epithelium, Hyperplasia                                       1 [2.0]                                                         
   Vagina                                             (1)                                                                           
      Cyst                                             1 [3.0]                                                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
b  Average severity grade (1-minimal;2-mild;3-moderate;4-marked)                                                                    
                                                                                                                                    
                                                             Page   14                                                              
                                                                                                                                   
NTP Experiment-Test: 96007-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT18  
Study Type: CHRONIC                                  WITH AVERAGE SEVERITY GRADES[b]                              Date: 10/01/03    
Route: GAVAGE                                   TOXIC EQUIVALENCY FACTOR EVALUATION (PCB-126)                     Time: 12:01:01    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         SPRAGUE-DAWLEY RATS FEMALE                   1000         1000 NG/                                                         
                                                      NG/KG        KG/STOP                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
HEMATOPOIETIC SYSTEM - CONT                                                                                                         
   Bone Marrow                                        (53)         (50)                                                             
      Atrophy                                          1 [3.0]                                                                      
      Hyperplasia                                     46 [3.3]     34 [3.1]                                                         
   Lymph Node                                         (12)         (2)                                                              
      Iliac, Ectasia                                                1 [2.0]                                                         
      Mediastinal, Angiectasis                         1 [2.0]                                                                      
      Mediastinal, Ectasia                             5 [1.8]                                                                      
      Mediastinal, Hemorrhage                          6 [2.0]                                                                      
      Mediastinal, Hyperplasia, Lymphoid               1 [2.0]                                                                      
      Mediastinal, Pigmentation                        2 [2.0]                                                                      
      Pancreatic, Hemorrhage                           1 [1.0]                                                                      
   Lymph Node, Mandibular                             (51)         (49)                                                             
      Atrophy                                          1 [3.0]                                                                      
      Ectasia                                          3 [2.3]      3 [2.3]                                                         
      Hemorrhage                                       1 [2.0]                                                                      
      Hyperplasia, Lymphoid                            1 [2.0]                                                                      
      Hyperplasia, Plasma Cell                        15 [2.1]     21 [2.3]                                                         
   Lymph Node, Mesenteric                             (53)         (50)                                                             
      Atrophy                                          1 [3.0]      2 [1.5]                                                         
      Ectasia                                          1 [2.0]                                                                      
      Hemorrhage                                       2 [1.5]                                                                      
      Hyperplasia, Histiocytic                         1 [2.0]      1 [2.0]                                                         
      Hyperplasia, Lymphoid                            2 [2.0]                                                                      
      Hyperplasia, Plasma Cell                                      1 [2.0]                                                         
   Spleen                                             (52)         (50)                                                             
      Hematopoietic Cell Proliferation                37 [1.6]     37 [1.5]                                                         
      Hyperplasia, Lymphoid                            3 [2.0]                                                                      
      Pigmentation                                    50 [1.3]     50 [1.6]                                                         
      Lymphoid Follicle, Atrophy                       6 [2.3]      4 [2.5]                                                         
      Red Pulp, Atrophy                                2 [2.5]                                                                      
   Thymus                                             (44)         (43)                                                             
      Atrophy                                         41 [3.5]     39 [3.0]                                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (53)         (50)                                                             
      Cyst                                             1 [3.0]     13 [2.7]                                                         
      Hyperplasia                                      9 [1.4]     22 [1.1]                                                         
   Skin                                               (53)         (50)                                                             
      Cyst, Squamous                                   1 [3.0]      2 [2.5]                                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
b  Average severity grade (1-minimal;2-mild;3-moderate;4-marked)                                                                    
                                                                                                                                    
                                                             Page   15                                                              
                                                                                                                                   
NTP Experiment-Test: 96007-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT18  
Study Type: CHRONIC                                  WITH AVERAGE SEVERITY GRADES[b]                              Date: 10/01/03    
Route: GAVAGE                                   TOXIC EQUIVALENCY FACTOR EVALUATION (PCB-126)                     Time: 12:01:01    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         SPRAGUE-DAWLEY RATS FEMALE                   1000         1000 NG/                                                         
                                                      NG/KG        KG/STOP                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Skeletal Muscle                                    (1)                                                                           
      Inflammation, Chronic Active                     1 [2.0]                                                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (53)         (50)                                                             
      Hemorrhage                                       1 [2.0]                                                                      
      Inflammation, Focal, Suppurative                 1 [3.0]                                                                      
      Necrosis, Focal                                  1 [3.0]                                                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (51)         (50)                                                             
      Hemorrhage                                       1 [2.0]      1 [2.0]                                                         
      Infiltration Cellular, Histiocyte               42 [1.5]     42 [1.5]                                                         
      Inflammation, Chronic Active                     2 [2.5]                                                                      
      Metaplasia, Squamous                             4 [1.8]                                                                      
      Mineralization                                   1 [2.0]      1 [2.0]                                                         
      Alveolar Epithelium, Metaplasia, Bronchiolar    40 [1.9]     32 [1.5]                                                         
      Serosa, Inflammation, Suppurative                             1 [3.0]                                                         
   Nose                                               (53)         (50)                                                             
      Goblet Cell, Respiratory Epithelium,                                                                                          
        Hyperplasia                                    1 [2.0]                                                                      
      Nasolacrimal Duct, Inflammation                  1 [3.0]      1 [3.0]                                                         
      Nasolacrimal Duct, Respiratory Epithelium,                                                                                    
         Hyperplasia                                   1 [3.0]                                                                      
      Nasopharyngeal Duct, Respiratory Epithelium,                                                                                  
         Hyperplasia                                   1 [3.0]                                                                      
      Respiratory Epithelium, Hyperplasia              1 [2.0]      1 [2.0]                                                         
      Turbinate, Cyst                                  1 [2.0]                                                                      
      Turbinate, Inflammation, Suppurative             4 [2.3]      1 [1.0]                                                         
      Vomeronasal Organ, Vacuolization Cytoplasmic     1 [2.0]                                                                      
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (52)         (50)                                                             
      Anterior Chamber, Inflammation, Suppurative      1 [3.0]      1 [3.0]                                                         
      Cornea, Inflammation, Suppurative                2 [2.5]      1 [3.0]                                                         
      Optic Nerve, Degeneration                        1 [2.0]                                                                      
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
b  Average severity grade (1-minimal;2-mild;3-moderate;4-marked)                                                                    
                                                                                                                                    
                                                             Page   16                                                              
                                                                                                                                   
NTP Experiment-Test: 96007-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT18  
Study Type: CHRONIC                                  WITH AVERAGE SEVERITY GRADES[b]                              Date: 10/01/03    
Route: GAVAGE                                   TOXIC EQUIVALENCY FACTOR EVALUATION (PCB-126)                     Time: 12:01:01    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         SPRAGUE-DAWLEY RATS FEMALE                   1000         1000 NG/                                                         
                                                      NG/KG        KG/STOP                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
SPECIAL SENSES SYSTEM - CONT                                                                                                        
      Retina, Atrophy                                  4 [2.5]                                                                      
   Harderian Gland                                    (52)         (50)                                                             
      Inflammation                                     6 [1.2]      9 [1.1]                                                         
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (53)         (50)                                                             
      Casts Protein                                    2 [1.5]      3 [1.7]                                                         
      Inflammation, Suppurative                        2 [2.0]                                                                      
      Mineralization                                  37 [1.0]     45 [1.0]                                                         
      Necrosis                                         1 [3.0]                                                                      
      Nephropathy                                     47 [2.1]     38 [1.4]                                                         
      Papilla, Necrosis                                1 [2.0]                                                                      
      Pelvis, Dilatation                               2 [3.5]      1 [2.0]                                                         
      Pelvis, Hemorrhage                               1 [3.0]                                                                      
      Pelvis, Inflammation, Chronic Active             1 [3.0]      1 [3.0]                                                         
      Pelvis, Metaplasia, Squamous                     1 [2.0]                                                                      
      Transitional Epithelium, Hyperplasia            11 [2.0]      2 [2.0]                                                         
   Ureter                                             (3)                                                                           
      Inflammation                                     1 [2.0]                                                                      
      Metaplasia, Squamous                             2 [2.5]                                                                      
      Mineralization                                   2 [3.5]                                                                      
      Transitional Epithelium, Hyperplasia             3 [3.0]                                                                      
   Urinary Bladder                                    (53)         (50)                                                             
      Inflammation                                     6 [1.5]      3 [1.3]                                                         
      Metaplasia, Squamous                             1 [2.0]                                                                      
      Transitional Epithelium, Hyperplasia             2 [3.0]                                                                      
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
b  Average severity grade (1-minimal;2-mild;3-moderate;4-marked)                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                             Page   17                                                              
                                                                                                                                   
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------